Table 3. Multivariate analysis of overall survival in patients with stage II pancreatic ductal adenocarcinoma.
Variables | N | HRa (95% CIa) | P value | |
---|---|---|---|---|
Differentiation | ||||
Well to moderate | 76 | 1.00 | ||
Poor | 29 | 1.01 (0.60–1.71) | 0.97 | |
Lymph node status (stage) | ||||
Negative (IIA) | 20 | 1.00 | ||
Positive (IIB) | 85 | 2.30 (1.19–4.44) | 0.013 | |
Margin status | ||||
Negative | 89 | 1.00 | ||
Positive | 16 | 2.22 (1.20–4.13) | 0.012 | |
MAP4K5 expression | ||||
High | 81 | 1.00 | ||
Low | 24 | 2.05 (1.17–3.56) | 0.012 |
aAbbreviations: HR, hazard ratio; CI, confidence interval.